- Home
- GASS vs CRVS Comparison
GASS vs CRVS Comparison
Compare GASS & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GASS
- CRVS
- Stock Information
- Founded
- GASS 2004
- CRVS 2014
- Country
- GASS Greece
- CRVS United States
- Employees
- GASS N/A
- CRVS N/A
- Industry
- GASS Marine Transportation
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- GASS Consumer Discretionary
- CRVS Health Care
- Exchange
- GASS Nasdaq
- CRVS Nasdaq
- Market Cap
- GASS 185.5M
- CRVS 206.5M
- IPO Year
- GASS 2005
- CRVS 2016
- Fundamental
- Price
- GASS $5.46
- CRVS $3.63
- Analyst Decision
- GASS
- CRVS Strong Buy
- Analyst Count
- GASS 0
- CRVS 3
- Target Price
- GASS N/A
- CRVS $15.67
- AVG Volume (30 Days)
- GASS 91.7K
- CRVS 906.6K
- Earning Date
- GASS 05-21-2025
- CRVS 05-05-2025
- Dividend Yield
- GASS N/A
- CRVS N/A
- EPS Growth
- GASS 38.69
- CRVS N/A
- EPS
- GASS 1.90
- CRVS N/A
- Revenue
- GASS $167,262,185.00
- CRVS N/A
- Revenue This Year
- GASS N/A
- CRVS N/A
- Revenue Next Year
- GASS $3.49
- CRVS N/A
- P/E Ratio
- GASS $2.81
- CRVS N/A
- Revenue Growth
- GASS 16.54
- CRVS N/A
- 52 Week Low
- GASS $4.82
- CRVS $1.43
- 52 Week High
- GASS $8.84
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- GASS 49.73
- CRVS 55.04
- Support Level
- GASS $4.94
- CRVS $3.15
- Resistance Level
- GASS $5.37
- CRVS $3.78
- Average True Range (ATR)
- GASS 0.20
- CRVS 0.25
- MACD
- GASS 0.03
- CRVS 0.12
- Stochastic Oscillator
- GASS 91.49
- CRVS 87.90
About GASS StealthGas Inc.
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).